Progress in work to develop cell-based therapies that can help treat diseases such as Type 1 diabetes has brought a prestigious Fulbright Scholar award to Jessica Weaver, an associate professor in the School of Biological and Health Systems Engineering, part of the Fulton Schools. In a collaboration with researchers at the Technion Israel Institute of Technology in Haifa, Israel, known for its expertise in engineering vasculature, Weaver’s team will be integrating lab-engineered vasculature from that lab with her lab’s computationally optimized cell therapy devices. The goal is to improve oxygen delivery to encapsulated cells to help improve the effectiveness of clinical treatments to fight disease.